Literature DB >> 31056158

Re-evaluation of abruptio placentae and other maternal complications during expectant management of early onset pre-eclampsia.

Helvi M Shoopala1, David R Hall2.   

Abstract

OBJECTIVE: Expectant management of appropriately selected cases of early pre-eclampsia in a dedicated, tertiary in-patient setting with frequent non-invasive maternal and fetal surveillance, prolongs pregnancy, improves perinatal outcome and mitigates the impact of maternal complications. As the rate of abruptio placentae in a large descriptive study performed nearly 20 years ago was 20%, a study to re-evaluate the rate of abruptio placentae and other maternal complications was performed. STUDY
DESIGN: A retrospective study that included all women admitted for expectant management with stable early pre-eclampsia (≥24 and <34 weeks' gestation) was performed at Tygerberg Hospital, a secondary and tertiary referral centre in South Africa over a period of 12 months. MAIN OUTCOME MEASURES: Abruptio placentae and other maternal complications.
RESULTS: During the study period, 9137 women were delivered at the study institution. The data of 102 of 106 women admitted for expectant management of early pre-eclampsia were available. Thirty-four (33%) reached the elective delivery threshold of 34 weeks. Seventeen women (17%) experienced ≥1 complication. There were four cases (4%) each with abruptio placentae, HELLP syndrome and renal insufficiency. Three of the cases with abruptio placentae were asymptomatic, only being diagnosed at caesarean section for fetal distress. Nine women developed mild/moderate ascites. There were no admissions to the critical care unit and no deaths.
CONCLUSIONS: Abruptio placentae occurred in 4% of women managed expectantly with early pre-eclampsia and was most often asymptomatic before delivery.
Copyright © 2019 International Society for the Study of Hypertension in Pregnancy. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Abruptio placenta; Ascites; Expectant management; Preeclampsia

Mesh:

Year:  2019        PMID: 31056158     DOI: 10.1016/j.preghy.2019.02.008

Source DB:  PubMed          Journal:  Pregnancy Hypertens        ISSN: 2210-7789            Impact factor:   2.899


  3 in total

1.  Epidemiology, Risk Factors, and Perinatal Outcomes of Placental Abruption-Detailed Annual Data and Clinical Perspectives from Polish Tertiary Center.

Authors:  Monika Bączkowska; Katarzyna Kosińska-Kaczyńska; Magdalena Zgliczyńska; Robert Brawura-Biskupski-Samaha; Beata Rebizant; Michał Ciebiera
Journal:  Int J Environ Res Public Health       Date:  2022-04-23       Impact factor: 4.614

2.  Maternal and perinatal outcome of preeclampsia without severe feature among pregnant women managed at a tertiary referral hospital in urban Ethiopia.

Authors:  Lemi Belay Tolu; Endale Yigezu; Tadesse Urgie; Garumma Tolu Feyissa
Journal:  PLoS One       Date:  2020-04-09       Impact factor: 3.240

3.  Diagnosis and Management of Pregnant Women With Placental Abruption and Neonatal Outcomes.

Authors:  Souhail Alouini; Antoine Valery; Bruno Lemaire; Marie-Liesse Evrard; Olivier Belin
Journal:  Cureus       Date:  2022-01-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.